Contribute
España
Italia
대한민국
日本
Français

Benzinga

Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
772.700.06%
QQQ
717.030.09%
BTC/USD
80957.980.3914%
DIA
536.820.02%
GLD
410.870.16%
TLT
82.140.09%

Alamar Biosciences Inc

ALMRNASDAQ
Trade with Public
Trade with Public
$30.57
0.080.26%
At close: Sep 3, 5:00 PM EST
$30.57
N/A
After Hours: 4:00 PM EST
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareStock Report

Alamar Biosciences Analyst Price Targets

Wall Street analyst price targets and consensus rating for Alamar Biosciences (ALMR).

Price Target Range — 2 Quarters

Analyst Consensus — 4 Analysts

4Buy
Consensus RatingBuy# Analysts4Avg. Consensus PT$33Upside to Avg. PT+7.9%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →
DateFirmAnalystActionRating ChangePrice Target
Aug 11, 2026StifelDaniel AriasPT RaiseBuy$28→$32
Aug 11, 2026JP MorganCasey WoodringPT RaiseOverweight$32→$35
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Stifel Maintains Buy on Alamar Biosciences, Raises Price Target to $32

Stifel analyst Daniel Arias maintains Alamar Biosciences (NASDAQ:ALMR) with a Buy and raises the price target from $28 to $32.
Benzinga Newsdesk

PRO
JP Morgan Maintains Overweight on Alamar Biosciences, Raises Price Target to $35

JP Morgan analyst Casey Woodring maintains Alamar Biosciences (NASDAQ:ALMR) with a Overweight and raises the price target from $32 to $35.
Benzinga Newsdesk

This Southwest Gas Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Analysts change outlook on top names. Check their ratings & price targets for AVEX, ALMR, TNDM, SWX, KLRA. See what they think of SWX stock.
Avi Kapoor

PRO
TD Cowen Initiates Coverage On Alamar Biosciences with Buy Rating, Announces Price Target of $30

TD Cowen analyst Dan Brennan initiates coverage on Alamar Biosciences (NASDAQ:ALMR) with a Buy rating and announces Price Target of $30.
Benzinga Newsdesk

PRO
JP Morgan Initiates Coverage On Alamar Biosciences with Overweight Rating, Announces Price Target of $30

JP Morgan analyst Casey Woodring initiates coverage on Alamar Biosciences (NASDAQ:ALMR) with a Overweight rating and announces Price Target of $30.
Benzinga Newsdesk

PRO
Stifel Initiates Coverage On Alamar Biosciences with Buy Rating, Announces Price Target of $28

Stifel analyst Daniel Arias initiates coverage on Alamar Biosciences (NASDAQ:ALMR) with a Buy rating and announces Price Target of $28.
Benzinga Newsdesk

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved